Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesAmortizatization of IntangiblesCapital ExpendituresCapital ExpendituresCash from Financing ActivitiesCash from Financing ActivitiesCash from Investing ActivitiesCash from Investing ActivitiesCash from OperationsCash from OperationsChange in Account PayablesChange in Account PayablesChange in Accured ExpensesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in Acquisitions & DivestmentsChange in CashChange in InventoryChange in InventoryChange in ReceivablesChange in ReceivablesChange in TaxesChange in TaxesDepreciation & Amortization (CF)Depreciation & Amortization (CF)Depreciation and DepletionDepreciation and DepletionFree Cash FlowFree Cash FlowGains from Investment SecuritiesGains from Investment SecuritiesNet Cash FlowNet Cash FlowNet IncomeShare-based CompensationShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Agios Pharmaceuticals (AGIO) Amortization of Deferred Charges (2019 - 2021)

Agios Pharmaceuticals (AGIO) has disclosed Amortization of Deferred Charges for 3 consecutive years, with $2.4 million as the latest value for Q3 2021.

  • For Q3 2021, Amortization of Deferred Charges rose 5.01% year-over-year to $2.4 million; the TTM value through Sep 2021 reached $9.4 million, up 5.66%, while the annual FY2019 figure was $8.5 million, N/A changed from the prior year.
  • Amortization of Deferred Charges hit $2.4 million in Q3 2021 for Agios Pharmaceuticals, up from $2.3 million in the prior quarter.
  • Across five years, Amortization of Deferred Charges topped out at $2.4 million in Q1 2021 and bottomed at $2.1 million in Q1 2019.
  • Average Amortization of Deferred Charges over 3 years is $2.2 million, with a median of $2.2 million recorded in 2020.
  • On a YoY basis, Amortization of Deferred Charges climbed as much as 9.71% in 2021 and fell as far as 4.97% in 2021.
  • Agios Pharmaceuticals' Amortization of Deferred Charges stood at $2.2 million in 2019, then grew by 2.97% to $2.3 million in 2020, then increased by 5.01% to $2.4 million in 2021.
  • According to Business Quant data, Amortization of Deferred Charges over the past three periods came in at $2.4 million, $2.3 million, and $2.4 million for Q3 2021, Q2 2021, and Q1 2021 respectively.